Home » Topics » Regulatory

Regulatory
RSS

Combinations of imidazoles for female genital infections

Dec. 1, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

New Zomig formulation receives European regulatory approval

Nov. 25, 1999

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Nov. 23, 1999

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

BMS seeks approval in U.S. for Glucophage XR tablets

Nov. 22, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.